Clinical study of NFLX (norfloxacin) in complicated urinary tract infections

The new chemotherapeutic agent NFLX was orally administered 600 mg a day for 5 consecutive days in 44 cases having complicated urinary tract infection, and its clinical efficacy was evaluated. They consisted of 8 marked effective cases, 19 moderately effective cases and 17 ineffective cases, and its...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 8 vom: 01. Aug., Seite 1167-75
1. Verfasser: Murase, T (VerfasserIn)
Weitere Verfasser: Mitsuya, H, Fukatsu, H, Yoshida, K, Natsume, H, Obata, K, Ohshima, S, Asaka, H, Kobayashi, M, Okamura, K
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1986
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Norfloxacin N0F8P22L1P
LEADER 01000caa a22002652 4500
001 NLM03769989X
003 DE-627
005 20250127003252.0
007 tu
008 231221s1986 xx ||||| 00| ||jpn c
028 5 2 |a pubmed25n0126.xml 
035 |a (DE-627)NLM03769989X 
035 |a (NLM)3788743 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a jpn 
100 1 |a Murase, T  |e verfasserin  |4 aut 
245 1 0 |a Clinical study of NFLX (norfloxacin) in complicated urinary tract infections 
264 1 |c 1986 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 12.01.1987 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a The new chemotherapeutic agent NFLX was orally administered 600 mg a day for 5 consecutive days in 44 cases having complicated urinary tract infection, and its clinical efficacy was evaluated. They consisted of 8 marked effective cases, 19 moderately effective cases and 17 ineffective cases, and its overall clinical efficacy was 61%. The bacteria disappeared in 10 cases, and decreased in 9 cases. Thirteen cases showed bacterial alternation, and 12 cases remained unchanged. By type of disease group, the efficacy was slightly inferior in the indwelling catheter group compared with that of the nonindwellt group 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a Norfloxacin  |2 NLM 
650 7 |a N0F8P22L1P  |2 NLM 
700 1 |a Mitsuya, H  |e verfasserin  |4 aut 
700 1 |a Fukatsu, H  |e verfasserin  |4 aut 
700 1 |a Yoshida, K  |e verfasserin  |4 aut 
700 1 |a Natsume, H  |e verfasserin  |4 aut 
700 1 |a Obata, K  |e verfasserin  |4 aut 
700 1 |a Ohshima, S  |e verfasserin  |4 aut 
700 1 |a Asaka, H  |e verfasserin  |4 aut 
700 1 |a Kobayashi, M  |e verfasserin  |4 aut 
700 1 |a Okamura, K  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Hinyokika kiyo. Acta urologica Japonica  |d 1962  |g 32(1986), 8 vom: 01. Aug., Seite 1167-75  |w (DE-627)NLM012631779  |x 0018-1994  |7 nnns 
773 1 8 |g volume:32  |g year:1986  |g number:8  |g day:01  |g month:08  |g pages:1167-75 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2018 
951 |a AR 
952 |d 32  |j 1986  |e 8  |b 01  |c 08  |h 1167-75